Discover the full record of transactions filed by HENNEY CHRISTOPHER S, Director. Insider active across 2 companies, notably Cyclacel Pharmaceuticals, Inc.. In total, 11 disclosures have been published. The latest transaction was filed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Christopher S. Henney is a Board Member at Cyclacel Pharmaceuticals, Inc. and PROTHENA CORP PUBLIC LTD CO. In these roles, he contributes to the governance of the companies and strategic decision-making. His experience in the pharmaceutical sector allows him to bring valuable insights to help guide development and innovation strategies.